TriSalus Life Sciences (TLSIW) Other financing activities (2023 - 2026)

TriSalus Life Sciences has reported Other financing activities for 4 years, with the latest figure at $263000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities fell 49.42% year-over-year to $263000.0; the trailing twelve-month figure through Mar 2026 stood at $243000.0 (down 92.21% YoY), and the FY2025 full-year result was $500000.0, down 80.77% from the prior year.
• Other financing activities for Q1 2026 stood at $263000.0, up from -$20000.0 in the prior quarter.
• The five-year high for Other financing activities was $2.6 million in Q4 2024, with the low at -$2.6 million in Q3 2024.
• Historically, Other financing activities has averaged $336300.0 across 4 years, with a median of $231316.5 in 2023.
• Annual changes were most pronounced in 2024 — Other financing activities jumped 1398.88% — and 2025, when it tumbled 100.77%.
• TriSalus Life Sciences' Other financing activities stood at -$199633.0 in 2023, then jumped by 1402.39% to $2.6 million in 2024, then plunged by 100.77% to -$20000.0 in 2025, then jumped by 1415.0% to $263000.0 in 2026.
• The last three Other financing activities figures came in at $263000.0 (Q1 2026), -$20000.0 (Q4 2025), and -$1.0 million (Q3 2025), per Business Quant data.